Loading company…
Ruiming Xinyao develops small molecule drugs for ophthalmic diseases.
Founded in 2018 and based in Suzhou, China, Ruiming Xinyao develops small molecule drugs for eye diseases, including vascular conditions and glaucoma. Its drug delivery format is eye drops. The company plans to use Series B funding for an IND application, clinical testing and new projects.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in